Company Overview and News
Chicago, IL – September 21, 2018 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include Wintrust Financial Corporation (WTFC - Free Report) , Comerica Incorporated (CMA - Free Report) , Blue Hills Bancorp, Inc. (BHBK - Free Report) , Union Bankshares Corporation (UBSH - Free Report) and First Financial Bankshares, Inc.
NCLH UBNC REGN CY CMA BHBK UBSH LB WTFCW WTFPP WTFC ON GIII FFIN CMPWW WTFCM CSBR BSTC WIFI VSH 3772 UNB
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
State-run Bank of India (BoI) Friday invited bids for sale of its stake in three associate companies namely STCI Finance, SIDBI and Equifax Credit Information Services.
It is a strong start for the Indian stock market this Friday morning with the Nifty50 up 89 points and is trading at 11,323 while the Sensex is trading higher by 294 points at 37,415.
523405 IOC RTI RLTAY 500325 82HP TCHQY PRMQY ASIANPAINT 532755 JUSTDIAL 532483 GAILF BEL JMFINANCIL RLNIY SBAZ BHQRY AXB 524804 532508 JETAIRWAYS YYBKY 530965 JSWSTEEL CNRYY TECHM AXBA TATASTEEL TATLY GAILY 500302 CANBK 506401 500188 HINDZINC 523367 500820 AUROPHARMA 533150 500228 RELIANCE 532617 HNDZY 532215 DEEPAKNI 500470 535648 532461 AXISBANK RIGD JSL YESBANK UBNC HINDALCO IBN 532648 PEL AXBKY HNDNF ICICIBANK GODREJPROP TTST PNJZY 532174 ARBQY 500366 PNB DCMSHRIRAM 500049 ROLTA JSTQY 500440
State Bank of India hopes to resolve 7-8 stressed power assets with an exposure of around Rs 17,000 crore during the breather given by the Supreme Court till November 11, SBI Chairman Rajnish Kumar said Thursday.
INDIANB UBNC PNJZY 532461 532483 532480 ALBK 532814 PNB CANBK SBAZ CNRYY
Bond yields rose on Sep 19, extending the week’s climb, as investors took escalating trade related tensions in stride, and focused more on solid economic data and promising corporate outlook. The yield on the 10-year Treasury note, a benchmark for interest rates, has hit a four-month high. The Federal Reserve, in fact, has stepped up the pace of monetary tightening, with Chairman Jerome Powell vouching for a steady path of interest rate hikes.
UBNC CMA BHBK UBSH WTFCW LB WTFPP WTFC FFIN CMPWW WTFCM UNB 3772
New Delhi : Mrutyunjay Mahapatra and Padmaja Chundru, both deputy managing directors in State Bank of India (SBI), have been appointed as managing director and chief executive officer of Syndicate Bank and Indian Bank respectively, according to an official order issued on Wednesday.
INDIANB UBNC UDBKL ALBK 532418 UBLS 532814 532505 SYNDIBANK 532276 532121 UBLA 532480 UCOBANK DENABANK ANDHRABANK SBAZ
The Indian stock market has turned negative this Wednesday with the Nifty50 down 50 points and is trading at 11,228 while the Sensex is trading lower by 185 points at 37,104.
UBNC MUTHOOTFIN MONSANTO GESHIP HFCL 533398 500183 500470 TTST TATASTEEL TATLY 524084 500620 DCMSHRIRAM 523367
The Indian stock market has turned negative this Wednesday afternoon with the Nifty50 down 28 points and is trading at 11,250 while the Sensex is trading lower by 82 points at 37,207.
MUTHOOTFIN 500325 532712 532832 533137 DEN RCOM SONATSOFTW 500179 GAILF BEL CLNDY RLNIY SBAZ BHQRY RELCAPITAL 532508 JETAIRWAYS JSWSTEEL 500182 TATASTEEL TATLY GAILY GLOBUSSPR COALINDIA IBREALEST 523367 533150 500228 RELIANCE 532617 533273 533398 533278 HCL-INSYS 532221 500470 RIGD HEROMOTOCO JSL 500111 UBNC 533104 OBZIY GODREJPROP TTST OBEROIRLTY DCMSHRIRAM HRTQY 500049
The Indian benchmark indices continues to trade in the red this Tuesday afternoon with the Nifty50 down 16 points and is trading at 11,361 while the Sensex is trading lower by 38 points at 37,547.
BAJAJ-AUTO INDIANB IOB 500325 UBL DABUR BRTQY 532712 DBRQY 532478 SYNDIBANK 500096 RCOM 532121 532483 SONATSOFTW 500696 500179 GAILF 500570 BRITANNIA RLNIY 504212 SBAZ AXB 532505 YYBKY CNRYY VIJAYABANK AXBA 532276 GAILY GLOBUSSPR CANBK 507458 ANDHRABANK 500825 RELIANCE 532814 532418 HINDUNILVR 532977 533155 JUBLFOOD 532215 HCL-INSYS 532388 532221 AXISBANK RIGD JBLWY TATAMOTORS UNIVCABLES YESBANK UBNC HINDALCO UBHOLDINGS 532648 UNBWY 533104 532401 AXBKY 532179 HNDNF CRPKY CORPBANK UCOBANK DENABANK 500440 TTM
The Indian stock market are trading in the red this Tuesday morning with the Nifty50 down 15 points and is trading at 11,362 while the Sensex is trading lower by 26 points at 37,559.
IOC INDIANB IOB 500325 UBL DABUR BRTQY TCHQY 532755 DBRQY 532478 500096 532121 532483 SONATSOFTW 500696 500179 GAILF BRITANNIA CLNDY RLNIY 504212 SBAZ AXB 532505 YYBKY 530965 CNRYY TECHM VIJAYABANK AXBA GAILY GLOBUSSPR CANBK 507458 COALINDIA ANDHRABANK 500825 524715 RELIANCE 532814 532418 HINDUNILVR 533155 JUBLFOOD 533278 532215 HCL-INSYS 532388 532221 AXISBANK RIGD JBLWY UNIVCABLES YESBANK UBNC HINDALCO UBHOLDINGS 532648 UNBWY 533104 532401 AXBKY 532179 HNDNF CRPKY SUNPHARMA CORPBANK UCOBANK DENABANK 500440
The government announced another step toward reform of PSU banks on Monday with merger of three PSBs Bank of Baroda, Vijaya Bank and Dena Bank but that seems to have not received well by the market on Tuesday.
INDIANB UBNC 500116 IDBI 532737 532418 532814 CNRYY 532401 VIJAYABANK SYNDIBANK 532276 EMKAY 532121 532483 CANBK DENABANK ANDHRABANK
The CBI has taken over investigation into alleged swindling of $171 million (about Rs 1,200 crore) from the Union Bank of India by hackers in 2016, officials said.
2018-09-18 - Asif
Overview Rigel Pharmaceuticals is a biotechnology company dedicated to discovering, developing and providing novel small molecule drugs that significantly improve the lives of patients with immune and hematologic disorders, cancer and rare diseases. The company's pioneering research focuses on signaling pathways that are critical to disease mechanisms. The company's first FDA-approved product is TAVALISSE™ (fostamatinib disodium hexahydrate), an oral spleen tyrosine kinase (SYK) inhibitor, for the treatment of adult patients with chronic immune thrombocytopenia who have had an insufficient response to a previous treatment. The company's current clinical programs include Phase 2 studies of fostamatinib in autoimmune hemolytic anemia and IgA nephropathy, and a Phase 1 study for its IRAK program. In addition, Rigel Pharmaceuticals has product candidates in development with partners BerGenBio AS, Daiichi Sankyo, and Aclaris Therapeutics. Since inception, Rigel Pharmaceuticals h...
2018-09-18 - Asif
Overview The company design, develop and sell exoskeleton technology to augment human strength, endurance and mobility. The company's exoskeleton technology serves multiple markets and can be used both by able-bodied users as well as by persons with physical disabilities. Ekso Bionics has sold, rented or leased devices that (a) enable individuals with neurological conditions affecting gait (stroke and spinal cord injury) to rehabilitate and to walk again and (b) allow industrial workers to perform heavy duty work for extended periods. Today, its medical exoskeleton, Ekso GT, is used as a rehabilitation tool to allow physicians and therapists to rehabilitate patients who have suffered a stroke or spinal cord injury. With its unique features designed specifically for hospitals and its proprietary SmartAssist software, Ekso GT allows for the early mobilization of patients, with high step count and high dosage treatments. The intent is to allow the patient’s central nervous syst...
2018-09-18 - Asif
Overview Agile Therapeutics is a forward-thinking women’s healthcare company dedicated to fulfilling the unmet health needs of today’s women. Twirla® and its other current potential product candidates are designed to provide women with contraceptive options that offer greater convenience and facilitate compliance. The company's lead product candidate, Twirla, also known as AG200-15, is a once-weekly prescription contraceptive patch that is at the end of Phase 3 clinical development. Since its inception in 1997, Agile Therapeutics has devoted substantial resources to developing Twirla, building its intellectual property portfolio, business planning, raising capital and providing general and administrative support for these operations. The company incurred research and development expenses of $14.4 million, $20.9 million and $25.6 million during the years ended December 31, 2017, 2016 and 2015, respectively. The company incurred research and development expenses of $2.4 milli...
as of ET